Texas dental anesthesia advisory report urges more detailed de-identified data, medical-consult guidance

The Texas State Board of Dental Examiners' Advisory Committee on Dental Anesthesia reviewed its March 7 report on sedation- and anesthesia-related incidents and deaths, discussed trends in patient selection and medical consultations, and recommended more precise de-identified reporting and educational outreach.

The committee told staff to solicit stakeholder feedback and to publish sample medical-consult templates and other practice resources in the agency newsletter and by posting a stakeholder feedback request. The committee also discussed whether future reports should separate deaths from nonfatal incidents to provide more actionable trends.

Why it matters: The committee examined 16 cases in 2025 and identified recurrent themes — comorbidity and poor patient selection, insufficient medical-clearance information, local-anesthetic dosing errors and the limits of reversal agents — that the committee said could be addressed through clearer guidance and better data collection.

What the committee discussed: Committee members and staff emphasized several areas for change. - Data granularity: Several members, including Dr. McNeil and Dr. Yu, urged separating deaths from nonfatal incidents and adding fields such as patient age, American Society of Anesthesiologists (ASA) class, level of sedation, procedure duration and estimated local anesthetic dose. Staff noted the rule requires de-identified reporting and said some categories are feasible to add while protecting confidentiality. - Medical consultations: Members said consult letters often lack details about procedure length, anticipated local anesthetic amounts, and redosing plans. The group discussed publishing a sample consult template for clinicians to share with primary care physicians so physicians have more context when advising on clearance. - Local anesthetic dosing and monitoring: Pediatric providers and others pushed for routine calculation of a patient's maximum local-anesthetic dose prior to cases, especially for children and long procedures, to reduce overdose risk. Some members worried that making the calculation a rule requirement would be overly burdensome for routine restorative visits; the committee favored recommending the calculation as a best practice and providing tools/resources (a member noted xchart.com as an example). - Reversal agents and recovery monitoring: The committee reiterated that reversal agents (for example, naloxone or flumazenil) can outlast their clinical effect window and that patients need continued monitoring after reversal to catch delayed respiratory depression.

Committee direction and next steps: Staff said it will publish the committee's recommendations and request stakeholder comment before the August meeting. Staff also agreed to provide the advisory committee earlier access to compiled data (age, ASA class, procedure length) going back to 2017 to support trend analysis. The committee discussed but did not direct formal rulemaking at this meeting.

Formal action: At the start of the meeting the committee also considered a separate item to amend Texas Administrative Code 107.400 (collection and reporting of enforcement and licensing data). The committee adopted the staff's proposed amendment, which will change the required internal staff report frequency from quarterly to yearly, and approved the amendment as presented.

Ending: The advisory committee asked staff to return with stakeholder feedback and proposed templates at the August meeting, and encouraged educators and continuing-education providers to highlight these findings in courses.